These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35480320)

  • 1. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma.
    Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J
    Front Genet; 2022; 13():835355. PubMed ID: 35480320
    [No Abstract]   [Full Text] [Related]  

  • 2. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 5. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
    Chen CC; Chu PY; Lin HY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma.
    Wang K; Chen X; Liu Y; Meng X; Zhou L
    Transl Cancer Res; 2024 Jul; 13(7):3536-3555. PubMed ID: 39145091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low
    Xie Z; Chen N
    Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration.
    Tang YF; Qiao B; Huang YB; Wang M
    Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220
    [No Abstract]   [Full Text] [Related]  

  • 11. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration.
    Yao Y; Chen H; Lou M; Chen T
    Front Genet; 2023; 14():1071694. PubMed ID: 36755576
    [No Abstract]   [Full Text] [Related]  

  • 13. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
    Zhao YW; Ma W; Jiang F; Xie Y; Tang L
    Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased expression of SEMA5B in gastric adenocarcinoma predicts poor prognosis: a study based on TCGA data].
    Cao H; Song XK; Hong YG
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):856-860. PubMed ID: 34407591
    [No Abstract]   [Full Text] [Related]  

  • 18. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma.
    Sun M; Qi S; Wu M; Xia W; Xiong H
    Front Genet; 2022; 13():909556. PubMed ID: 36338983
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
    Sun X; Liu P
    Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
    Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
    J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.